CytoDyn (CYDY) News Today → The Best AI Stock to Own in the World Today is Trading for Just $25 (From Banyan Hill Publishing) (Ad) Free CYDY Stock Alerts $0.14 0.00 (0.00%) (As of 04/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineCytoDyn Inc. (OTCMKTS:CYDY) Short Interest Updatemarketbeat.com - April 15 at 11:14 PMCytoDyn Inc. (OTCMKTS:CYDY) Sees Large Decline in Short Interestmarketbeat.com - March 3 at 10:23 PMCytoDyn Says FDA Lifts Hold On Leronlimabmarkets.businessinsider.com - February 29 at 1:22 PMFDA lifts clinical hold on CytoDyn drug, stock rallies 22%msn.com - February 29 at 1:22 PMCytoDyn Announces FDA Has Lifted Clinical Holdglobenewswire.com - February 29 at 8:30 AMCytoDyn Inc CYDYmorningstar.com - February 10 at 2:26 AMCytoDyn Submits Revised HIV Clinical Trial Protocol To FDA, Starts Glioblastoma Pre-Clinical Studymarkets.businessinsider.com - February 1 at 2:24 PMCytoDyn Announces Submission of Clinical Protocol to FDA and Initiation of Pre-Clinical Study in Glioblastomafinance.yahoo.com - February 1 at 2:24 PMCytoDyn Announces Submission of Clinical Protocol to FDA and Initiation of Pre-Clinical Study in Glioblastomatmcnet.com - February 1 at 9:23 AMInvestors file another lawsuit against CytoDynbizjournals.com - January 31 at 7:26 PMCytoDyn Releases Regulatory FD Disclosure Informationmsn.com - January 30 at 6:24 PMCytoDyn Announces Executive Leadership Changes and Appointmentsmsn.com - January 30 at 8:32 AMVancouver biotech appoints new CEO, as former top executive awaits fraud trialbizjournals.com - January 29 at 8:01 PMCytoDyn Inc.: CytoDyn Appoints Jacob Lalezari M.D. as CEO, Mitchell Cohen as Interim CFOfinanznachrichten.de - January 29 at 3:01 PMCytoDyn appoints Jacob Lalezari as CEO, Mitchell Cohen as interim CFOmsn.com - January 29 at 10:00 AMCytoDyn Appoints Jacob Lalezari M.D. as CEO, Mitchell Cohen as Interim CFOfinance.yahoo.com - January 29 at 10:00 AMCytoDyn Announces Webcast to Provide Company Updatefinance.yahoo.com - December 7 at 5:52 PMCytoDyn appoints Lalezari as its interim CEOmsn.com - November 22 at 12:19 AMCytoDyn Inc.: CytoDyn Appoints Jacob Lalezari M.D. as Interim CEOfinanznachrichten.de - November 21 at 9:14 AMCytoDyn Appoints Jacob Lalezari M.D. as Interim CEOfinance.yahoo.com - November 21 at 9:14 AMFormer biotech execs in 'brazen fraud' case want indictments dismissedbizjournals.com - September 21 at 11:57 AMCytoDyn (OTC: CYDY)fool.com - August 2 at 12:32 AMCytoDyn leader on taking HIV treatment back to FDA, is upbeat about Amarex litigationbizjournals.com - July 24 at 8:22 PMDevelopments in OTC Stocks Under a Quarter (CSTF, CYDY, IMHC, BRLL)benzinga.com - July 13 at 10:35 AMCytoDyn hits up former business partner for $100M in damagesbizjournals.com - July 12 at 6:27 PMCytoDyn Announces Company Updates and Investment Community Update Webcastfinance.yahoo.com - July 11 at 9:09 PMCytoDyn President Cyrus Arman takes medical leaveseekingalpha.com - May 25 at 8:39 AMCytoDyn Inc.: CytoDyn Announces President Takes Medical Leave of Absencefinanznachrichten.de - May 25 at 3:39 AMCytoDyn Announces President Takes Medical Leave of Absencefinance.yahoo.com - May 24 at 5:38 PMCytoDyn to Hold Webcast to Provide a Company Updatefinance.yahoo.com - April 5 at 10:48 AMA Court Case With High Implications For The Tech Sector And Inflation Still Higher Than Expected - Forbes AI Newsletter February 25thforbes.com - February 27 at 5:55 PMCytoDyn Inc. (CYDY) stock historical prices & data – Yahoo Financenz.finance.yahoo.com - January 15 at 7:09 PMCytoDyn: There Seems To Be No Redemptionseekingalpha.com - December 31 at 1:46 PMCytoDyn to Hold Webcast to Discuss the Performance of Leronlimab in Clinical Trials and Recent Charges Against Former CEOfinance.yahoo.com - December 23 at 1:26 PMCytoDyn to Host R&D Update on Wednesday, December 7, 2022finance.yahoo.com - November 22 at 4:43 PMCytoDyn Announces Appointment of Additional Directors with Industry Experiencefinance.yahoo.com - October 20 at 6:01 PMCytoDyn Announces Appointment of Additional Directors with Industry Experience - GlobeNewswireglobenewswire.com - October 20 at 8:52 AMForm 10-Q/A CytoDyn Inc. For: Aug 31 - StreetInsider.comstreetinsider.com - October 13 at 10:37 PMCytoDyn Inc. (CYDY)finance.yahoo.com - September 8 at 3:25 PMTranscript : CytoDyn Inc. - Shareholder/Analyst Call - Marketscreener.commarketscreener.com - September 1 at 11:39 PMCytoDyn : OTCQB Certification - Marketscreener.commarketscreener.com - September 1 at 4:20 AMCYTODYN INC. : Change in Directors or Principal Officers (form 8-K) - Marketscreener.commarketscreener.com - August 30 at 9:42 PMSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CytoDyn Inc. - CYDY - GuruFocus.comgurufocus.com - August 27 at 12:59 PMSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CytoDyn Inc. - CYDY - GlobeNewswireglobenewswire.com - August 24 at 10:40 PMCytoDyn: It Only Takes One Hit (OTCMKTS:CYDY) - Seeking Alphaseekingalpha.com - August 24 at 10:40 PMCYTODYN INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K) - Marketscreener.commarketscreener.com - August 16 at 11:40 AMBronstein, Gewirtz & Grossman, LLC Notifies Shareholders of CytoDyn Inc. (CYDY) Investigation - Benzingabenzinga.com - August 9 at 5:27 PMSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CytoDyn Inc. - CYDY - PR Newswireprnewswire.com - August 9 at 7:26 AMCYTODYN INC. : Non-Reliance on Previous Financials, Audits or Interim Review (form 8-K) - Marketscreener.commarketscreener.com - August 5 at 10:38 PMCytoDyn : Statement of Changes in Beneficial Ownership - Form 4 - Marketscreener.commarketscreener.com - August 4 at 9:20 PM Get CytoDyn News Delivered to You Automatically Sign up to receive the latest news and ratings for CYDY and its competitors with MarketBeat's FREE daily newsletter. Email Address The “Next Bitcoin”? 10 CENT Crypto Set to Explode (Ad)The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon… Click For My #1 FREE Crypto for 2024 CYDY Media Mentions By Week CYDY Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CYDY News Sentiment▼0.000.32▲Average Medical News Sentiment CYDY News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CYDY Articles This Week▼00▲CYDY Articles Average Week Get CytoDyn News Delivered to You Automatically Sign up to receive the latest news and ratings for CYDY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: CRVO News Today RGLS News Today CAPR News Today CYBN News Today NWPHF News Today IMAB News Today IXHL News Today BPTS News Today SYRS News Today AEON News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:CYDY) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithProtect Your Bank Account Before It’s Too LateWeiss RatingsBiden out June 13; Kamala won’t replace him?Paradigm PressThe World's First "$20 Trillion Drug?"Behind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CytoDyn Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
